Lizhu Pharmaceuticals (01513.HK) has repurchased a cumulative total of 11.3189 million A shares by the end of April.

Zhixin Finance APP News, Lee's Pharmaceutical (01513.HK) announced that as of April 30, 2025, the company has repurchased a total of 11.3189 million shares of the company's A shares through centralized bidding trading, accounting for 1.24% of the total share capital of the company. The highest purchase price was RMB 38.37 per share and the lowest purchase price was RMB 33.21 per share. The total amount of funds used was RMB 407 million (excluding transaction costs). The repurchase mentioned above complies with the company's established share repurchase plan.